Muscle News and Research

RSS

Researchers discover new mechanism that contributes to airway hyperresponsiveness in asthma

In asthma, the airways become hyperresponsive. Researchers from Uppsala University have found a new mechanism that contributes to, and explains, airway hyperresponsiveness.

13 Mar 2021

Unbalanced progesterone may cause preterm or prolonged labor in some pregnant women

New research by the National Institutes of Health found that unbalanced progesterone signals may cause some pregnant women to experience preterm labor or prolonged labor.

11 Mar 2021

Study examines central nervous system imaging manifestations of COVID-19 in children

While neurological complications of COVID-19 in children are rare, in contrast to adults, an international expert review of positive neuroimaging findings in children with acute and post-infectious COVID-19 found that the most common abnormalities resembled immune-mediated patterns of disease involving the brain, spine, and nerves.

10 Mar 2021

Researchers study the effects of cocaine on patients diagnosed with schizophrenia

Alejandro Fuertes-Saiz, fourth-year Psychiatry intern at the Hospital Provincial de Castellón and doctoral candidate at the CEU Cardenal Herrera (CEU UCH) University of Valencia, along with his thesis directors, Gonzalo Haro and Ana Benito, have just published in journal Brain Science the final results of three year-long research where they have studied the effects of cocaine on patients diagnosed with schizophrenia or antisocial personality disorder.

10 Mar 2021

Researchers confirm new drug development route for treating multiple sclerosis, asthma

Brazilian researchers who study a native venomous fish have confirmed a route to drug development for the treatment of chronic inflammatory diseases such as multiple sclerosis and asthma.

10 Mar 2021

Scientists use silk from transgenic silkworm to grow skeletal muscle cells

Researchers at Utah State University are using silkworm silk to grow skeletal muscle cells, improving on traditional methods of cell culture and hopefully leading to better treatments for muscle atrophy.

10 Mar 2021

App-based treatment for urinary incontinence was as effective as in-person treatment

A mobile app designed to help women manage urinary incontinence was as effective as usual, in-person treatment of incontinence in primary care, according to new research from the Netherlands.

10 Mar 2021

Super-resolution system microscopy can reveal pluripotency and differentiation of live stem cells

A new super-resolution system microscopy can assess the pluripotency and differentiation of live stem cells, spearheading a new era in stem-cell research and systems biology.

9 Mar 2021

Five herbal medicines show potent activity against Babesia duncani in the lab

Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the U.S., today announced the publication of new data finding that five herbal medicines had potent activity compared to commonly-used antibiotics in test tubes against Babesia duncani, a malaria-like parasite found on the West Coast of the U.S. that causes the disease babesiosis.

9 Mar 2021

Compounds in green and black tea relax blood vessels by activating ion channel proteins

A new study from the University of California, Irvine shows that compounds in both green and black tea relax blood vessels by activating ion channel proteins in the blood vessel wall.

8 Mar 2021

Multisystem intervention could potentially prevent or reverse frailty, research shows

Physicians understand frailty as a dysregulation among multiple systems in the body that make it less resilient and unable to recover completely when faced with a physical challenge such as injury or illness.

8 Mar 2021

Study reveals physical phenomena relied by oocytes to grow big

Egg cells are by far the largest cells produced by most organisms. In humans, they are several times larger than a typical body cell and about 10,000 times larger than sperm cells.

8 Mar 2021

UH pharmacologist to explore cause and treatment for left ventricular non-compaction cardiomyopathy

University of Houston pharmacologist Mingfu Wu has been awarded $2.5 million from the National Heart, Lung, and Blood Institute to explore the cause of and therapeutic treatment for left ventricular non-compaction cardiomyopathy (LVNC).

5 Mar 2021

New evidence supports the use of antisense oligonucleotides as feasible therapeutic strategy for MDS

Many cognitive neurodevelopmental disorders are a result of too many or too few copies of certain genes or chromosomes.

5 Mar 2021

Preclinical study finds immune benefit in unrefrigerated Soligenix coronavirus vaccines

A new study reports positive outcomes from two new vaccine candidates. The research, led by Axel T. Lehrer from the University of Hawaii at Manoa, studied mice's immune response when administered the CoVaccine HT adjuvant with an insect-cell expressed SARS-CoV-2 spike protein ectodomain.

4 Mar 2021

Inflammatory heart disease is rare among professional athletes with mild COVID-19, study finds

Inflammatory heart disease is a rare finding among professional athletes with mild or asymptomatic COVID-19 infection, a large-scale study has found.

4 Mar 2021

Study reveals potential risk factors for developing nerve damage after cancer treatment

A low hemoglobin count, older age and high BMI are possible risk factors for developing nerve damage after cancer treatment, a UNSW-led study has found.

4 Mar 2021

Coronavirus deranges the immune system in complex and deadly ways

There's a reason soldiers go through basic training before heading into combat: Without careful instruction, green recruits armed with powerful weapons could be as dangerous to one another as to the enemy.

4 Mar 2021

Study: Salivary gland ectasia reflects hyperinflammatory response to COVID-19

The clinical picture of COVID-19 in various target organs has been extensively studied and described, but relatively little is known about the characteristics of oral cavity involvement.

4 Mar 2021

Results from phase 2 trial of Novavax recombinant nanoparticle SARS-CoV-2 vaccine

Novavax, Inc., the American vaccine development company, has been developing a recombinant protein nanoparticle COVID-19 vaccine currently termed NVX-CoV2373. The full-length spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is created in a baculovirus vector, which is then inserted into a lipid nanoparticle around 50 nm in diameter.

3 Mar 2021

Muscle News and Research

Researchers discover new mechanism that contributes to airway hyperresponsiveness in asthma

Unbalanced progesterone may cause preterm or prolonged labor in some pregnant women

Study examines central nervous system imaging manifestations of COVID-19 in children

Researchers study the effects of cocaine on patients diagnosed with schizophrenia

Researchers confirm new drug development route for treating multiple sclerosis, asthma

Scientists use silk from transgenic silkworm to grow skeletal muscle cells

App-based treatment for urinary incontinence was as effective as in-person treatment

Super-resolution system microscopy can reveal pluripotency and differentiation of live stem cells

Five herbal medicines show potent activity against Babesia duncani in the lab

Compounds in green and black tea relax blood vessels by activating ion channel proteins

Multisystem intervention could potentially prevent or reverse frailty, research shows

Study reveals physical phenomena relied by oocytes to grow big

UH pharmacologist to explore cause and treatment for left ventricular non-compaction cardiomyopathy

New evidence supports the use of antisense oligonucleotides as feasible therapeutic strategy for MDS

Preclinical study finds immune benefit in unrefrigerated Soligenix coronavirus vaccines

Inflammatory heart disease is rare among professional athletes with mild COVID-19, study finds

Study reveals potential risk factors for developing nerve damage after cancer treatment

Coronavirus deranges the immune system in complex and deadly ways

Study: Salivary gland ectasia reflects hyperinflammatory response to COVID-19

Results from phase 2 trial of Novavax recombinant nanoparticle SARS-CoV-2 vaccine

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News